Profil
Dr. Daniel J.
Chai is a Founder & Managing Partner at Turret Capital Management, LP, a Chief Executive Officer at Egret Therapeutics, Inc. and an Executive Chairman at Milu Labs Ltd.
Dr. Chai was previously employed as a Partner & Portfolio Manager by Iguana Healthcare Management LLC, a Portfolio Manager by Surveyor Capital Ltd., a Senior Analyst by Merlin Biomed Group Hedge Funds, a Managing Director by NEUBERGER BERMAN LLC, a Managing Director by Tucker Anthony Sutro, a Vice President by Furman Selz LLC, a Portfolio Manager by Citadel Enterprise Americas LLC, and a Portfolio Manager by UBS Investment Bank (US).
He received his undergraduate degree from the University of Michigan and a doctorate degree from Columbia University Vagelos College of Physicians & Surgeons.
Postes actifs de Daniel Chai
| Sociétés | Poste | Début |
|---|---|---|
Milu Labs Ltd.
 Milu Labs Ltd. Medical/Nursing ServicesHealth Services Milu Labs Ltd. operates as a medical diagnostics company that builds, researches, and markets technologies to screen and detect major health conditions. The company was founded by Daniel Joon-byung Chai, Wilson Zhang, and Matthew G. Badalucco and is headquartered in New York, NY. | Fondateur | - |
Turret Capital Management, LP
 Turret Capital Management, LP Investment ManagersFinance Turret Capital Management LP (Turret Capital) is a venture capital firm founded in 2016 by Daniel Chai. The firm is headquartered in New York. | Fondateur | 01/01/2016 |
Egret Therapeutics, Inc.
 Egret Therapeutics, Inc. BiotechnologyHealth Technology Egret Therapeutics, Inc. is a clinical-stage biotherapeutics company that aims to become a leading biotechnology company. The company is based in New York, NY. The company focuses on discovering, developing, and commercializing novel therapies that transform treatment paradigms in the management of life-threatening neurological conditions. The company's product development and commercial execution strategies are geared towards achieving this vision. Egret Therapeutics was founded by Daniel Joon-byung Chai, Michael Lim, and Chris Jackson, with Daniel Joon-byung Chai serving as the CEO since incorporation. | Directeur Général | - |
Anciens postes connus de Daniel Chai
| Sociétés | Poste | Fin |
|---|---|---|
Merlin Biomed Group Hedge Funds
 Merlin Biomed Group Hedge Funds Investment ManagersFinance Founded in 1998 by Dr. Stuart T. Weisbrod, New York City-based Merlin BioMed Group LLC manages a family of funds that encompass hedge funds, a long-term capital appreciation fund and private equity funds. Their investor base consists of institutions, pension funds, endowments, funds of funds, family offices and high net worth individuals. | Analyst-Equity | 30/11/2007 |
Neuberger Berman BD LLC
 Neuberger Berman BD LLC Investment ManagersFinance Neuberger Berman BD LLC is a SEC-registered investment advisor and mutual fund manager headquartered in New York City. It is directly owned by Neuberger Berman Investment Advisers LLC, which is an indirect, wholly-owned subsidiary of Neuberger Berman Group LLC, which is owned by NBSH Acquisition LLC. The firm traces their origin back to the 1939 founding of Neuberger & Berman, its predecessor firm. In 1950, Neuberger Berman became one of the first firms to offer a no-load mutual fund to individual investors. Neuberger Berman BD manages a range of equity, fixed income, private equity and hedge fund strategies on behalf of institutions, advisors and individual investors worldwide. | Analyst-Equity | 31/12/2003 |
| Tucker Anthony Sutro | Analyst-Equity | 31/12/1999 |
| Furman Selz LLC | Analyst-Equity | 31/12/1997 |
UBS Investment Bank (US)
 UBS Investment Bank (US) Investment Banks/BrokersFinance UBS Investment Bank provides investment banking and securities brokerage services. Its clients include institutional and corporate clients, intermediaries, governments, and hedge funds. The firm also provides merger and acquisition advisory, private placement, investment research, foreign exchange, equity, and leverage finance advisory services. The firm is headquartered in San Francisco, CA. | Gestionnaire de Portefeuille-Actions | - |
Formation de Daniel Chai
| University of Michigan | Undergraduate Degree |
| Columbia University Vagelos College of Physicians & Surgeons | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 11 |
|---|---|
Merlin Biomed Group Hedge Funds
Merlin Biomed Group Hedge Funds Investment ManagersFinance Founded in 1998 by Dr. Stuart T. Weisbrod, New York City-based Merlin BioMed Group LLC manages a family of funds that encompass hedge funds, a long-term capital appreciation fund and private equity funds. Their investor base consists of institutions, pension funds, endowments, funds of funds, family offices and high net worth individuals. | Finance |
| Furman Selz LLC | Finance |
Neuberger Berman BD LLC
Neuberger Berman BD LLC Investment ManagersFinance Neuberger Berman BD LLC is a SEC-registered investment advisor and mutual fund manager headquartered in New York City. It is directly owned by Neuberger Berman Investment Advisers LLC, which is an indirect, wholly-owned subsidiary of Neuberger Berman Group LLC, which is owned by NBSH Acquisition LLC. The firm traces their origin back to the 1939 founding of Neuberger & Berman, its predecessor firm. In 1950, Neuberger Berman became one of the first firms to offer a no-load mutual fund to individual investors. Neuberger Berman BD manages a range of equity, fixed income, private equity and hedge fund strategies on behalf of institutions, advisors and individual investors worldwide. | Finance |
| Tucker Anthony Sutro | Finance |
Surveyor Capital Ltd.
 Surveyor Capital Ltd. Investment ManagersFinance Surveyor Capital Ltd. is a hedge fund seeding platform headquartered in New York City. The firm was founded in 2008 and is a subsidiary of Citadel LP, which is owned by GFH HFEVA LLC. Surveyor Capital manages capital exclusively for Citadel’s multi-strategy funds and its positions are consolidated in Form 13F filed by Citadel Advisors LLC. | Finance |
Iguana Healthcare Management LLC
 Iguana Healthcare Management LLC Investment ManagersFinance Founded in 2010, Iguana Healthcare Management LLC is a hedge fund manager and registered investment advisor located in New York City. The firm's s clients include pooled investment vehicles (e.g. hedge funds) that it sponsors, high net-worth individuals and non-US persons. | Finance |
Citadel Enterprise Americas LLC
 Citadel Enterprise Americas LLC Investment ManagersFinance Citadel Enterprise Americas LLC (Citadel Enterprise) is a hedge fund management firm headquartered in Miami, Florida. Formerly known as Citadel LLC, the firm was founded by Kenneth C. Griffin and Reade Griffith in 1990. They are a subsidiary of Citadel Group Holdings LP, ultimately held by GFH HFEVA LLC. Citadel Enterprise provides investment banking, institutional trading and fund administration services to various clients. | Finance |
UBS Investment Bank (US)
UBS Investment Bank (US) Investment Banks/BrokersFinance UBS Investment Bank provides investment banking and securities brokerage services. Its clients include institutional and corporate clients, intermediaries, governments, and hedge funds. The firm also provides merger and acquisition advisory, private placement, investment research, foreign exchange, equity, and leverage finance advisory services. The firm is headquartered in San Francisco, CA. | Finance |
Milu Labs Ltd.
Milu Labs Ltd. Medical/Nursing ServicesHealth Services Milu Labs Ltd. operates as a medical diagnostics company that builds, researches, and markets technologies to screen and detect major health conditions. The company was founded by Daniel Joon-byung Chai, Wilson Zhang, and Matthew G. Badalucco and is headquartered in New York, NY. | Health Services |
Turret Capital Management, LP
Turret Capital Management, LP Investment ManagersFinance Turret Capital Management LP (Turret Capital) is a venture capital firm founded in 2016 by Daniel Chai. The firm is headquartered in New York. | Finance |
Egret Therapeutics, Inc.
Egret Therapeutics, Inc. BiotechnologyHealth Technology Egret Therapeutics, Inc. is a clinical-stage biotherapeutics company that aims to become a leading biotechnology company. The company is based in New York, NY. The company focuses on discovering, developing, and commercializing novel therapies that transform treatment paradigms in the management of life-threatening neurological conditions. The company's product development and commercial execution strategies are geared towards achieving this vision. Egret Therapeutics was founded by Daniel Joon-byung Chai, Michael Lim, and Chris Jackson, with Daniel Joon-byung Chai serving as the CEO since incorporation. | Health Technology |
